Paliperidone Palmitate

This is a medicine used to treat schizophrenia, a type of mental illness. It works by blocking certain brain chemicals called dopamine and serotonin, which helps reduce symptoms like hallucinations and delusions. It's often given as an injection under the skin.

Brand names:Invega Sustenna
Medication

What people taking Paliperidone Palmitate report

Every report comes from a Lived member, sent anonymously.

Have you tried Paliperidone Palmitate for Schizophrenia?

NameHow it went

About Paliperidone Palmitate

What It's For

Paliperidone palmitate is a long-acting injectable antipsychotic used to treat schizophrenia in adults. It is best known as Invega Sustenna, a once-a-month injection, which is also approved for schizoaffective disorder, a condition that combines psychotic symptoms such as hallucinations or delusions with episodes of depression or mania. For schizoaffective disorder it can be used on its own or alongside a mood stabilizer or antidepressant. Erzofri is another monthly paliperidone palmitate injection with the same two approved uses. Two longer-acting versions are used only for schizophrenia, and only after someone is already doing well on a shorter one. Invega Trinza is given every three months to people who have been adequately treated with the monthly injection for at least four months. Invega Hafyera is given every six months to adults who have been stable on the monthly injection for at least four months or on the three-month injection for at least one cycle. The main reason to choose an injection over a daily pill is steadier treatment. Missing antipsychotic doses is a common path to relapse, and an injection given in a clinic removes the need to remember a tablet every day while making it clear to the care team whether a dose has been received.

How It Works

After injection into a muscle, paliperidone palmitate dissolves very slowly. The body gradually converts it into paliperidone, the active medicine, which then enters the bloodstream over weeks to months. Paliperidone is the main active breakdown product of risperidone (Risperdal), an older antipsychotic, so the two medicines are closely related. Paliperidone blocks two types of receptors in the brain: dopamine D2 receptors and serotonin 5-HT2A receptors. Overactive dopamine signaling in certain brain pathways is thought to contribute to hallucinations, delusions and disorganized thinking, and dampening it can reduce these symptoms. Exactly how this translates into benefit in schizophrenia is not fully understood. The same dopamine blocking also explains several of its side effects, such as restlessness, stiffness and raised levels of prolactin, a hormone involved in breast milk production.

Dosage & Administration

Every injection is given by a healthcare professional, usually at a clinic, into the upper arm (deltoid) or buttock (gluteal) muscle. It is never self-injected. People who have never taken paliperidone or risperidone usually take one of them as a tablet first to make sure they tolerate it before receiving a long-acting dose that cannot be removed. With Invega Sustenna, treatment starts with two injections in the upper arm one week apart, which bring levels up quickly. Monthly injections then follow in the arm or buttock. Erzofri starts with a single higher arm injection, followed by monthly doses. The dose is adjusted to how well symptoms are controlled and how side effects are tolerated. Invega Trinza (every three months) and Invega Hafyera (every six months, buttock only) are started at the time the next shorter-interval injection would have been due, at a dose matched to the previous one. Keeping appointments matters. The monthly injection can be given up to a week before or after the scheduled date, but a longer gap may mean restarting with extra injections. If an appointment is missed, contact the clinic to rebook rather than waiting for the next scheduled one. People with mild kidney problems receive lower doses.

Side Effects

Common side effects include pain, swelling or a lump where the injection was given, sleepiness, dizziness and headache. Some people feel akathisia, an inner restlessness and urge to keep moving, or notice stiffness, tremor or slowed movement. These movement effects are called extrapyramidal symptoms and can often be eased by adjusting the dose or adding another medicine. Weight gain and rises in blood sugar and cholesterol can occur with this type of antipsychotic, so these are checked at the start and during treatment. Increased thirst, frequent urination or unusual hunger can be signs of high blood sugar and are worth reporting. Higher prolactin levels are common and can cause missed or irregular periods, milky discharge from the breasts, lower sex drive, erectile problems or breast enlargement in men; tell the prescriber if these appear. Dizziness or fainting on standing up is most likely at the start of treatment or after a dose increase. Tardive dyskinesia is a less common but important risk: involuntary movements, often of the lips, tongue or face, that can become permanent. The risk rises with longer treatment, and any new repetitive movements should be reported early. Neuroleptic malignant syndrome is rare but life-threatening. A high fever with very stiff muscles, confusion, a fast or irregular heartbeat, or heavy sweating needs emergency care right away. An erection that is painful or lasts for hours also needs immediate medical attention.

Interactions & Warnings

Paliperidone palmitate should not be used by anyone who has had an allergic reaction to paliperidone or risperidone. It is not recommended for people with moderate to severe kidney impairment, because the kidneys remove most of the drug. Like all antipsychotics, it carries an FDA boxed warning: older adults with dementia who are treated with antipsychotics for psychosis have a higher risk of death, mostly from heart problems or infections such as pneumonia. It is not approved for psychosis related to dementia. Some medicines lower paliperidone levels enough to make it less effective, including carbamazepine (a seizure and mood medicine), rifampin (an antibiotic used for tuberculosis) and the herbal supplement St. John's wort. These are best avoided during treatment. Paliperidone can modestly lengthen the QT interval, a measure of the heart's electrical recovery between beats, so it is generally avoided in people with long QT syndrome or a history of abnormal heart rhythms, and combined cautiously with other medicines that have the same effect. It can also blunt the effect of levodopa and similar Parkinson's medicines. Alcohol and other sedating medicines, such as sleeping pills, opioids or some antihistamines, can add to drowsiness and slowed thinking. Until you know how the medicine affects you, take care with driving or operating machinery. Antipsychotics can also make it harder for the body to cool down, so take extra care to stay hydrated during heat or strenuous exercise. For pregnancy, the decision balances the risk of relapse from stopping treatment against possible effects on the baby. Babies exposed in the last three months of pregnancy can have temporary movement or withdrawal symptoms after birth, such as jitteriness, stiffness, sleepiness or feeding difficulty. Because one injection remains in the body for months, anyone planning pregnancy or breastfeeding should discuss it with the prescriber ahead of time.

What to Expect

Because the medicine is released slowly, it does not wear off between visits the way a daily pill might. A single monthly injection can still be releasing drug about four months later. This is helpful for steady symptom control, but it also means a side effect cannot be stopped quickly, and a dose change can take several months to show its full effect. In studies of adults with schizophrenia who were already stable on monthly injections, about 10% of those who continued had a relapse during the study, compared with 34% of those switched to a placebo injection. Response still varies from person to person, and the injection works best as part of broader care that may include therapy, social support and help with work or housing. Regular appointments are an opportunity to review symptoms, side effects, weight, blood sugar and cholesterol. People who stay stable on the monthly form may be able to move to the three-month or six-month injection, which means fewer visits. Schizophrenia is usually a long-term condition, so treatment is often continued for years, and any decision to reduce or stop should be made with the prescriber, with a plan for watching for early signs of relapse.

Questions to Ask Your Doctor

  1. 1.What are the advantages of a long-acting injection for me compared with a daily tablet?
  2. 2.Which version and schedule would suit me, and could I eventually move to a three-month or six-month injection?
  3. 3.What side effects should I watch for in the first months, and what can we do about restlessness, weight gain or hormonal changes?
  4. 4.How will we monitor my weight, blood sugar and cholesterol, and how often?
  5. 5.What happens if I miss an injection appointment, and how would we plan if I want to become pregnant or stop treatment?

Last reviewed • Oct 2026

Educational content, not medical advice.